Zai Lab Ltd (ZLAB)
25.70
-0.53
(-2.02%)
USD |
NASDAQ |
Nov 21, 16:00
25.70
0.00 (0.00%)
After-Hours: 20:00
Zai Lab Debt to Equity Ratio: 0.1692 for Sept. 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2024 | 0.1692 |
| June 30, 2024 | 0.0998 |
| March 31, 2024 | 0.0633 |
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.00 |
| Date | Value |
|---|---|
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.00 |
| September 30, 2020 | |
| June 30, 2020 | 0.0091 |
| March 31, 2020 | |
| December 31, 2019 | 0.0219 |
| September 30, 2019 | 0.0189 |
| December 31, 2018 | 0.0145 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Dec 2020
0.1692
Maximum
Sep 2024
0.0202
Average
--
Median
Dec 2020
Debt to Equity Ratio Benchmarks
| Concord Medical Services Holdings Ltd | -1.575 |
| 111 Inc | -0.3074 |
| Dr Reddy's Laboratories Ltd | 0.1435 |
| WuXi Biologics (Cayman) Inc | 0.0531 |
| Sinovac Biotech Ltd | 0.0358 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 985.35M |
| Total Liabilities (Quarterly) | 317.68M |
| Shareholders Equity (Quarterly) | 667.67M |
| Current Ratio | 3.006 |
| Net Debt Paydown Yield | -0.95% |